U.S. Markets closed

Analyzing BEAT, SUPN, ADBE And RHT Stocks

Amanda Lawrence
Analyzing BEAT, SUPN, ADBE And RHT Stocks

BioTelemetry’s (BEAT) net income has declined at a 3-year and 5-year average of 17% and 5.9% respectively. The company’s negative pre-tax margin changed from 5.5% in 2013 to 3.6% in 2017. The stock prices have beaten the diagnostics & research industry and S&P 500 between 2013 and 2017. The market cap had gained 373% between 2013 and 2017.